Search

Your search keyword '"Mielke, Michelle."' showing total 2,840 results

Search Constraints

Start Over You searched for: Author "Mielke, Michelle." Remove constraint Author: "Mielke, Michelle."
2,840 results on '"Mielke, Michelle."'

Search Results

1. Diagnosis of Alzheimer’s disease using plasma biomarkers adjusted to clinical probability

4. Acceptable performance of blood biomarker tests of amyloid pathology — recommendations from the Global CEO Initiative on Alzheimer’s Disease

5. Dual cognitive and mobility impairments and future dementia - Setting a research agenda.

6. The Alzheimer's Association appropriate use recommendations for blood biomarkers in Alzheimer's disease

7. Consideration of sex and gender in Alzheimer's disease and related disorders from a global perspective

8. Physical Activity and Trajectory of Cognitive Change in Older Persons: Mayo Clinic Study of Aging

12. A blood screening tool for detecting mild cognitive impairment and Alzheimer's disease among community‐dwelling Mexican Americans and non‐Hispanic Whites: A method for increasing representation of diverse populations in clinical research

24. Perspectives on ethnic and racial disparities in Alzheimer's disease and related dementias: Update and areas of immediate need.

25. Association of plasma biomarkers of amyloid and neurodegeneration with cerebrovascular disease and Alzheimer's disease

26. CSF phosphorylated tau as an indicator of subsequent tau accumulation

28. Tau polygenic risk scoring: a cost-effective aid for prognostic counseling in Alzheimer’s disease

30. White matter damage due to vascular, tau, and TDP-43 pathologies and its relevance to cognition

31. Global neuropathologic severity of Alzheimer’s disease and locus coeruleus vulnerability influences plasma phosphorylated tau levels

33. Deep learning identifies brain structures that predict cognition and explain heterogeneity in cognitive aging

34. Artificial Intelligence–Enabled Electrocardiogram for Atrial Fibrillation Identifies Cognitive Decline Risk and Cerebral Infarcts

35. 1H MR spectroscopy biomarkers of neuronal and synaptic function are associated with tau deposition in cognitively unimpaired older adults

36. Changes in Alzheimer Disease Blood Biomarkers and Associations With Incident All-Cause Dementia.

37. Cerebrospinal fluid dynamics and discordant amyloid biomarkers

40. Cognitive impairment and World Trade Centre-related exposures

42. Associations among plasma, MRI, and amyloid PET biomarkers of Alzheimer's disease and related dementias and the impact of health‐related comorbidities in a community‐dwelling cohort

45. Effect of cerebrovascular risk factors on the prediction of Alzheimer’s disease neuropathologic change using plasma biomarkers (N4.003)

46. Nonalcoholic Fatty Liver Disease and Longitudinal Change in Imaging and Plasma Biomarkers of Alzheimer Disease and Vascular Pathology

47. CSF biomarkers of immune activation and Alzheimer’s disease for predicting cognitive impairment risk in the elderly

48. Plasma glial fibrillary acidic protein in the visual and language variants of Alzheimer's disease

Catalog

Books, media, physical & digital resources